Carmen Shaw (she/her) is a global bioeconomy and health security policy specialist. She is currently a PhD student in Biodefense and International Security at George Mason University and Managing Editor of The Pandora Report, GMU’s biodefense policy newsletter. Her research focuses on adaptive governance frameworks for emerging risks at the intersection of biotechnology and artificial intelligence (AI). She previously served as Director of the International Bioeconomy Forum at the National Academies of Sciences, Engineering, and Medicine (NASEM), where she led international initiatives on bioeconomy governance, emerging biotechnology, and global health security. She has co-led major efforts to counter zoonotic spillover of high-consequence pathogens in live animal supply chains in Southeast Asia and supported biotechnology cooperation under the U.S.-India Initiative on Critical and Emerging Technology (iCET). Her work has convened hundreds of experts across government, academia, industry, and public-private partnerships to address dual-use biotechnology challenges, pandemic preparedness, and international policy coordination. A 2020-21 Fulbright Scholar to Thailand, she advanced STEM education while partnering with U.S. embassies in Bangkok and Vientiane, Laos. Originally from Atlanta, Georgia, she holds a Master of Science in Population Biology, Ecology, and Evolution from Emory University and a Bachelor of Science in Biological Sciences from Georgia State University.